Just In
- 2 hrs ago Mahavir Jayanti 2024: Date, Time, History, Celebrations And Teachings Of Lord Mahavir In Jainism
- 3 hrs ago Parineeti Chopra Saree Looks: Check Amar Singh Chamkila Actor's Regal Fashion Statements
- 5 hrs ago Vidya Balan's 'Do Aur Do Pyaar' Urban Boho Style Avatar Is Relatable And Inspiring, Check Her Modern Avatar!
- 13 hrs ago Golden Rules To Follow For Happy Marriage For A Long Lasting Relationship
Don't Miss
- Education UPMSP Class 10 and 12 Results 2024 to be Released Today, Check the Details Here
- News CJI Chandrachud Urges For Voters: Don't Miss Voting In 2024 General Elections
- Movies Do Aur Do Pyaar Box Office Collection Day 1: Vidya-Pratik's Rom-Com Fails To Rake In Moolah On Opening Day
- Sports Virat Kohli Record Against Kolkata Knight Riders and at Eden Gardens Ahead Of RCB vs KKR IPL 2024 Match 36
- Finance Want To Be Debt Free? 5 Simple Ways To Repay Your Loan Faster
- Automobiles Tesla CEO Elon Musk's Much-Awaited Visit to India Deferred, Leaving Questions Unanswered
- Technology Garena Free Fire Max Redeem Codes for April 20, 2024: Get Access to the Latest In-game Loot
- Travel Journey From Delhi To Ooty: Top Transport Options And Attractions
New Therapy To Treat Inoperable Melanoma
A study at University of Pittsburgh Cancer Institute (UPCI) has cited that the combination of two different biotherapies may turn out to be more beneficial for patients with inoperable melanoma.
The researchers used two biotherapies, treatments that stimulate the immune system to fight cancer, and found that the results were quite promising in terms of anti-tumor effects and tolerable in terms of toxicity.
It was the first time that the researchers combined two biotherapies in this phase 2 trial. The biotherapies were: High-dose interferon alfa-2b, a standard treatment for metastatic skin cancer, and tremelimumab, an antibody thought to instigate the body"s immune system.
“With each new study, we learn something important about melanoma. With this study, we learned that adding tremelimumab to traditional treatment is not only safe, but an effective way to induce an anti-tumor response, which is very exciting," said John M. Kirkwood, M.D., leader of the program and professor and vice chairman for clinical research in the Department of Medicine, University of Pittsburgh School of Medicine.
In the study, the combination treatment was given to 16 patients diagnosed with stage 4 melanoma, all of whom received and had not benefited from at least one round of previous therapy
It was found that the overall response rate was 19 percent, and after that the study entered the second stage, where it will enroll 21 patients more.
Melanoma is a rare form of skin cancer, causing the majority of skin cancer-related deaths. Each year, approximately 160,000 new cases are diagnosed worldwide, and currently surgery is the only effective cure.
In case of patients with inoperable disease, like those enrolled in this study, such discovery of a safe and effective treatment holds a big importance.
The study was presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
- disorders cureActinic Keratosis: Causes, Symptoms, Risk Factors, Treatments And Prevention
- disorders cureMoles: Types, Causes, Symptoms, Risk Factors, Treatments And Prevention
- nutrition14 Fascinating Benefits Of Galangal
- newsHere Is A New Treatment That Helps Prevent The Spread Of Skin Cancer; Causes Of Skin Cancer
- wellnessParkinson's May Be Linked To Melanoma: Study
- disorders cureWarning Signs Of Melanoma
- healthBoost Your Immunity This Monsoon Season With These 3 Refreshing Drinks
- healthMyths vs Facts: Is Turmeric Good For Immunity?
- nutritionTherapeutic Benefits Of Tulsi And Recipes
- wellness9 Daily Habits To Improve Immunity
- healthImmune Response Induced By Omicron Effectively Neutralises Delta Variant: ICMR Study
- wellnessAmazing Health Benefits Of Black Garlic: Good For The Heart, Digestive Health And Immunity